Evidence map›Paper›PMID 39727479›Full record

ArticleAntibodies (Basel, Switzerland)2024

Increased Levels of Anti-

Juan Carlos Andreu-Ballester, Amparo Navarro, Miguel Angel Arribas, Moises Rico, Laura Albert, Carlos García-Ballesteros, Lorena Galindo-Regal, Rosa Sorando-Serra, Francisca López-Chuliá, Federico Peydro and 3 more

Abstract read
In one paragraph

Article in Antibodies (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Anisakiasis: A Decade of Molecular and Diagnostic Advancements (2015-2026).International journal of molecular sciences · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Juan Carlos Andreu-BallesterFISABIO Foundation-Public Health of Valencia, 46015 Valencia, Spain.ORCID 0000-0003-3790-3054
Amparo NavarroCritical Care Department, Arnau de Vilanova University Hospital, 46015 Valencia, Spain.
Miguel Angel ArribasCritical Care Department, Arnau de Vilanova University Hospital, 46015 Valencia, Spain.
Moises RicoCritical Care Department, Arnau de Vilanova University Hospital, 46015 Valencia, Spain.
Laura AlbertCritical Care Department, Arnau de Vilanova University Hospital, 46015 Valencia, Spain.
Carlos García-BallesterosLaboratory of Molecular Biology, Arnau de Vilanova University Hospital, 46015 Valencia, Spain.
Lorena Galindo-RegalLaboratory of Molecular Biology, Arnau de Vilanova University Hospital, 46015 Valencia, Spain.ORCID 0000-0002-0607-1630
Rosa Sorando-SerraEmergency Department, Arnau de Vilanova University Hospital, 46015 Valencia, Spain.
Francisca López-ChuliáFISABIO Foundation-Public Health of Valencia, 46015 Valencia, Spain.
Federico PeydroCritical Care Department, Arnau de Vilanova University Hospital, 46015 Valencia, Spain.
Marta RoderoParasitic Immunobiology and Immunomodulation Research Group (INMUNOPAR), Complutense University, 28040 Madrid, Spain.
Juan González-FernándezParasitic Immunobiology and Immunomodulation Research Group (INMUNOPAR), Complutense University, 28040 Madrid, Spain.ORCID 0000-0002-0306-8399
Carmen CuéllarParasitic Immunobiology and Immunomodulation Research Group (INMUNOPAR), Complutense University, 28040 Madrid, Spain.ORCID 0000-0001-7948-9889

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesIn a previous study, we described elevated anti-

methodsWe recruited 80 subjects: 40 patients with sepsis and 40 controls. αβ and γδ T cells were analyzed using flow cytometry. Apoptosis was also assessed, and anti-

resultsIn the second analysis (7-10 after sepsis evolution), an increase in all specific antibody isotypes was identified in individuals with septic shock, except IgE. The levels of anti-

conclusionsOur results suggest a previous infection by

Indexed as

anti-Anisakis antibodiesapoptosisELISAmortalitysepsisαβ T cellsγδ T cells

Identifiers

PMID39727479
PMCPMC11672462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.